Home » Topics » Regulatory » Patents

Patents
RSS

Bayer reports LTB4 synthesis inhibitors for asthma

Aug. 12, 1997

MMP/TNF-alpha inhibitors from Novartis

Aug. 12, 1997

Orally active PDE IV inhibitors from Merck Frosst

Aug. 11, 1997

Oral carbapenem antibacterial agents from Lederle (Japan)

Aug. 11, 1997

Cephalon reports cysteine/serine protease inhibitors with broad therapeutic potential

Aug. 11, 1997

Tacrine analogs reported for Alzheimer's disease

Aug. 8, 1997

Protein kinase C inhibitors discovered at Cephalon

Aug. 8, 1997

SKB reports new agents for atherosclerosis

Aug. 8, 1997

Atypical beta-adrenoceptor agonists from Glaxo Wellcome

Aug. 7, 1997

New analgesic/antiinflammatory compounds from Korea

Aug. 7, 1997

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026